Woodard Jr Joseph Paul 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Jun 11, 2019
Insider Transaction Report
Form 4
Woodard Jr Joseph Paul
SVP Clinical & Medical Affairs
Transactions
- Award
Stock Option (right to buy)
2019-06-11+37,500→ 37,500 totalExercise: $1.87Exp: 2029-06-10→ Common Stock (37,500 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest and become exercisable on January 1, 2020, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.